UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG

UFUR and Iressa

Iressa 250 mg daily plus UFUR 1# bid

Trial Locations (1)

112

Taipei VGH, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT01037998 - UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | Biotech Hunter | Biotech Hunter